Rapidly alternating combination of cisplatinbased chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: Results of a phase I-II study by the GOTHA group

This publication has 24 references indexed in Scilit:

• Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro
  Carcinogenesis: Integrative Cancer Research, 1992
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma
  JNCI Journal of the National Cancer Institute, 1992
• Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 Patients
  JNCI Journal of the National Cancer Institute, 1991
• Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer association of antitumor activity with initial tumor burden and treatment center
  Cancer, 1990
• Effective sample sizes for confidence intervals for survival probabilities
  Statistics in Medicine, 1987
• Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approach
  Cancer, 1981
• Censored Data and the Bootstrap
  Journal of the American Statistical Association, 1981
• Estimation of confidence limits for the cumulative probability of survival in life table analysis
  Journal of Chronic Diseases, 1978
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958